The reappearance of a forgotten disease in the oral cavity: syphilis by Viñals Iglesias, Helena & Chimenos Küstner, Eduardo
e416
Med Oral Patol Oral Cir Bucal. 2009 Sep 1;14 (9):e416-20.                                                                                                                                                                   Reappearance of oral syphilis
Journal section: Oral Medicine and Pathology
Publication Types: Review 
The reappearance of a forgotten disease in the oral cavity: Syphilis
Helena Viñals-Iglesias 1, Eduardo Chimenos-Küstner 2 
1 Associate lecturer in oral medicine, Faculty of Dentistry, University of Barcelona
2 Tenured lecturer in oral medicine, Faculty of Dentistry, University of Barcelona
Correspondence: 
Passeig de Sant Joan, 80, 2º 1ª
08009-Barcelona. Spain
hvinyals@gmail.com
Received: 30/09/2008
Accepted: 20/03/2009
Viñals-Iglesias H, Chimenos-Küstner E. The reappearance of a forgotten 
disease in the oral cavity: Syphilis. Med Oral Patol Oral Cir Bucal. 2009 
Sep 1;14 (9):e416-20.   
 http://www.medicinaoral.com/medoralfree01/v14i9/medoralv14i9p416.pdf
Abstract
Syphilis is a sexually transmitted disease (STD) produced by Treponema pallidum, which mainly affects humans 
and is able to invade practically any organ in the body. Its infection facilitates the transmission of other STDs. 
Since the end of the last decade, successive outbreaks of syphilis have been reported in most western European 
countries. Like other STDs, syphilis is a notifiable disease in the European Union. In Spain, epidemiological infor-
mation is obtained nationwide via the country’s system for recording notifiable diseases (Spanish acronym EDO) 
and the national microbiological information system (Spanish acronym SIM), which compiles information from 
a network of 46 sentinel laboratories in twelve Spanish regions. The STDs that are epidemiologically controlled 
are gonococcal infection, syphilis, and congenital syphilis. The incidence of each of these diseases is recorded 
weekly. The information compiled indicates an increase in the cases of syphilis and gonococcal infection in Spain 
in recent years. According to the EDO, in 1999, the number of cases of syphilis per 100,000 inhabitants was re-
corded to be 1.69, which has risen to 4.38 in 2007. In this article, we review the reappearance and the evolution of 
this infectious disease in eight European countries, and alert dentists to the importance of a) diagnosing sexually-
transmitted diseases and b) notifying the centres that control them.
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Introduction
Syphilis is a sexually-transmitted disease (STD) pro-
duced by Treponema pallidum, a microaerophilic spi-
rochete which mainly infects humans and which is able 
to invade practically any organ in the body. Its infection 
facilitates the transmission of other STDs (1). 
The presumptive diagnosis of the infection can be made 
clinically. However, a number of points should be borne 
in mind. First, dentists working today are less familiar 
with syphilis than their predecessors, who worked at 
times when the prevalence of the disease was higher; 
so they should be alert to suggestive oral lesions and in-
clude them in the list of differential diagnoses. Second, 
the oral and systemic clinical manifestations of syphilis 
may resemble those of other entities, and third, both the 
clinical manifestations and the habitual diagnosis may 
be masked by the presence of coinfection with other 
pathogens such as the HIV virus.
Syphilis has two main clinical stages: early and late. 
Early or infectious syphilis (recently acquired, or of 
less than two years’ duration) is the more contagious 
stage, and includes the primary and secondary forms 
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and the early latent period. Primary syphilis appears af-
ter an incubation period of between one and four weeks, 
typically in the form of an erosive, indurated, painless 
chancre–usually only one–and always accompanied by 
regional, multiple, enlarged, rubbery and discrete ad-
enopathies (2). Nonetheless, primary syphilis is often 
asymptomatic; the initial lesion is genital in approxi-
mately 85% of cases, anal in 10%, and oropharyngeal in 
4% (3). After 4-6 weeks the infection spreads through 
the blood and the lymph vessels, presenting non-spe-
cific signs and symptoms and disseminated mucocuta-
neous and systemic lesions. The clinical manifestations 
of the secondary form are polymorphous, and syphilids 
are the most frequently found mucocutaneous lesions. 
Mucosal plaques (Fig.1 and 2) are the most frequent oral 
manifestation of this secondary stage; the organs are not 
usually affected. Tertiary syphilis, which is extremely 
rare, may appear three years or more after the initial in-
fection. The characteristic lesion is the gumma, which 
in the oral cavity may affect the palate, the tongue or 
the tonsils (2).
The decisive breakthrough in syphilis treatment was 
made in the 1940s, with the introduction of penicillin 
and the success of the prevention campaigns carried out 
in the US and Europe. After this spectacular reduction, 
the disease re-emerged in the 1960s due to a series of 
behaviours that we will call the “three p’s” –permissive-
ness, promiscuity, and the pill. In the 1970s, with the 
application of new control measures, the prevalence fell 
once more. Since then, in industrialized countries, the 
pattern of behaviour of syphilis consists of sudden rises 
in the numbers of individuals infected, followed by pe-
riods of low prevalence every 5 to 10 years. In 1999, 
unprecedentedly low rates of syphilis were recorded in 
the US (2.5 cases/100,000 inhabitants), due to the in-
fluence of HIV prevention campaigns (4). Today, how-
ever, after the effective control of AIDS in the US and 
Europe, preventive measures in sexual behaviour are 
becoming relaxed, and this relaxation has contributed 
to the appearance of new outbreaks of syphilis (and of 
other STDs) – especially among male homosexuals, in 
whom the proportion of HIV positives is higher than 
average (5-14), Without greater control of the situation, 
new outbreaks of syphilis (and AIDS and other STDs) 
are to be expected in industrialized countries. Adequate 
preventive measures are required not only in the prac-
tice of ano-genital sex but in oral sex as well (7,9,10, 
15-17). In the latter case, the oral cavity is the gateway 
to infection.
The situation in Spain
Like other STDs, syphilis is a notifiable disease in Eu-
ropean Union countries. In Spain, nationwide epide-
miological information is obtained from the EDO and 
the SIM, which compile information via a network of 
46 sentinel laboratories in twelve of the country’s re-
gions. The STDs that are epidemiologically control-
led are gonococcal infection, syphilis and congenital 
syphilis, the number of cases of these diseases being 
recorded weekly. The information compiled indicates 
in recent years an increase in the cases of syphilis and 
gonococcal infection notified in Spain. In fact, the EDO 
records show that the rates of syphilis rose from 1.69 
per 100,000 inhabitants in 1999 to 4.38 per 100,000 
inhabitants in 2007 (18,19). However, since numerical 
recordings do not provide data on the characteristics of 
the new cases notified, in May 2005 an STD working 
group was set up, comprising 14 diagnosis centres from 
seven regions of Spain. In Catalonia, the rate of syphilis 
was 3.7 cases/100,000 inhabitants in 2005 (an increase 
of 176.1% over 2000) and 5.2 cases/100,000 inhabitants 
in 2006 (12).
The situation in the European Union 
In the European Union, the reference centres for epi-
demiological surveillance of STDs provide relatively 
Fig. 1. Mucosal plaque of secondary syphilis in the 
retrocommissural area.
Fig. 2. Syphilid on the edge of the tongue in a male 
homosexual.
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thorough and accurate information on the current state 
of syphilis. Constant efforts are made to improve the 
notification systems (6-10).
As a response to the outbreak in Europe, the ESSTI 
(The European Surveillance of Sexually Transmitted 
Infections) set up a working group to study preventive 
measures in use against HIV/syphilis in MSM (men 
who have sex with men) (9).
(Table 1) shows the cases of infectious syphilis in the 
EU. We compared epidemiological data in several ur-
COUNTRY-REGION-CITY          YEAR                    CHARACTERISTICS  
 
SPAIN (15-16,24)                     2002-2003                  95% males 
(Barcelona)                                                                   Mean age 34 years 
                                                                                      86%  MSM* (Men who have Sex with Men)  
                                                                                      68%   born in Spain                                  
                                                                                      19%   born in Latin America  
                                                                                        9%   from Eastern European countries  
                                                                                      37%   VIH+ 
                                                                                      high  incidence of Hepatitis A  
 
BELGIUM (6)                  Oct 2000- Mar 2004          93.4% males 
(Antwerp, Brussels)                                                     Mean age (males) 37 years  
                                                                                     79,9% MSM   
                                                                                     14,7% heterosexuals  
                                                                                     76,1% born in Belgium 
                                                                                      9,8% other European nationalities 
                                                                                      4,3% born in Latin America  
                                                                                      50,5 % VIH+ 
                                                                                      25,9% history of Hepatitis B   
 
DENMARK (11)                    2003-2004                     96% males  
(Copenhaguen)                                                             78% MSM  
                                                                                      75% resident in the Copenhagen area 
                                                                                      70% syphilis acquired “domestically” 
                                                                                      37% of MSM were HIV +                                                                                       
 
FRANCE (7)                             2000-2003                 Mean age (males) 36,5 years 
(Île de France, Paris)                                                   75-87% MSM   
                                                                                     70 % born in France  
                                                                        83% relations with “casual” sexual partners                                                                                              
                                                                                      33-60 % VIH+. 
 
GERMANY (8)                          1997-2003                75% MSM 
 (Frankfurt, Cologne,                                                    High nº of  heterosexuals cases 
 Berlin, Hamburg, Munich)                                         prevalence  >  50%  of VIH + among MSM 
 
REPUBLIC OF             Jan 2000- Dec 2003                88,1% males   
IRELAND (9)                                                               Mean age (males) 35 years 
 (Dublin)                                                                        66,5% homosexuals  
                                                                                       83,6 % MSM 
                                                                                       31% of  MSM practised unprotected oral sex   
                                                                                       68,9% patients born in Ireland 
                                                                                       18,1% patients born outside Ireland 
                                                                                       High prevalence among VIH+  
 
CZECH                         1994-2001                               incidence: 3,6-9,6/100.000 inhab. 
REPUBLIC   (21)                                                          higher prevalence in urban areas with high levels of prostitution 
                                            
                                                                                       high prevalence among refugees                                                                            
                                                                                       high incidence of congenital syphilis (0.1-0.2/ 100.000 inhab.) 
 
UNITED KINGDOM  April 2001-Set 2004                  66% MSM   
KINGDOM  (10)                                                            32,3% heterosexuals 
 (London)                                                                        89% white homosexuals born in the United Kingdom  
                                                                                        high incidence among blacks not born in UK 
                                                                                        high rates of prostitution 
                                                                                        53% of  MSM were  HIV + 
 
Table 1. The cases of infectious syphilis in the EU.
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ban areas with high rates of incidence in eight European 
countries: Spain (Barcelona), Denmark (Copenhagen), 
Belgium (Antwerp and Brussels), France (Île de France 
and Paris), Germany (Frankfurt, Cologne, Berlin and 
Hamburg), Republic of Ireland (Dublin), the Czech Re-
public and the United Kingdom (London).
Cases of syphilis were defined in accordance with the 
recommendations of the WHO and the European au-
thorities (20). These include the clinical presumptive 
diagnosis and direct visualization of spirochetes in 
clinical samples (or more often in serology tests, since 
Treponema pallidum cannot be cultivated in vitro) 
(6-8,21).  
Diagnostic Tools
In addition to clinical suspicion and direct visualization 
of spirochetes, two types of serology test are available 
(1,22): 
a) non-treponemic tests–VDRL or RPR–which are 
based on the detection of antibodies Ig M or Ig G (rea-
gins) in the serum of patients with syphilis which react 
to antigens containing cardiolipin-cholesterol-lecithin; 
these tests are inexpensive and are used for screening or 
follow-up of treated patients. 
b) treponemic tests based on absorption (FTA-ABS), 
microhemagglutination (MHA-TP) and agglutination 
(TPPA), are used for confirmatory purposes if the non-
treponemic tests are positive. Epidemiological data are 
also obtained from patients with syphilis, and tests for 
HIV are performed.  
Therapy
The treatment of choice for primary and non-compli-
cated secondary syphilis is a single dose of penicillin G 
benzathine of 2.4 million UI administered by intramus-
cular route. In the case of allergy, doxycycline may be 
used (100mg administered orally, twice a day for two 
weeks) or tetracycline, which offers similar levels of ef-
ficacy (23). In general, HIV patients can be treated in 
the same way as seronegative patients (1).
Discussion
We found certain similarities in the syphilis outbreaks 
in the different European countries studied. The preva-
lence of the disease among male homosexuals is higher 
than among heterosexuals in almost all the areas under 
analysis. The highest number of cases recorded corre-
sponds to men who have sex with other men (MSM), 
who in many cases were aware of their coinfection with 
HIV; these findings suggest that male homosexuals re-
main a reservoir for syphilis, presenting an increase in 
high-risk sexual behaviours and a reduction in the use 
of protective measures. For example, in Barcelona, 4% 
of cases of primary syphilis are located in the orophar-
ynx (3), supporting the notion that some syphilis out-
breaks are due to the practice of unprotected oral sex. 
The prevalence of syphilis in women is lower than in 
men in Europe. Though most infected patients were liv-
ing in their native country, some cases were immigrants 
or refugees (in Spain, Belgium, Ireland, Germany, the 
Czech Republic and the UK). The infection is more fre-
quent in the large cities or in the surrounding regions. 
(6-10,15,16,24).
There are many reasons for the increase in prevalence 
of the disease. The main cause is the practice of unpro-
tected ano-genital and oral sex. The lifestyle of many 
subjects is characterized by risk situations, such as 
frequenting saunas, bars, and clubs in search of casual 
contacts (9), blind dates arranged in Internet; low-cost 
travel between different European countries and the 
activity of prostitution networks imported from south-
eastern and eastern Europe have also increased preva-
lence (5). 
An aspect that is difficult to assess is the influence of 
HIV on syphilis. Atypical forms of syphilis have fre-
quently been reported in HIV-positive patients, with a 
faster course and with more florid systemic manifesta-
tions than in the seronegative population (1,25). Primary 
syphilis is often asymptomatic and the initial lesion is 
extragenital in a considerable number of cases (26,27). 
Secondary syphilis and latent infection are the most 
usual forms of presentation in HIV positive patients 
(25,28).  Skin lesions in the form of generalized maculo-
papular eruptions are the most common manifestations 
of secondary syphilis (1,28). The presence of HIV in the 
diagnosis of syphilis may alter the serological response. 
First, HIV-positive patients may present negative serol-
ogy during the primary and secondary syphilis more 
often than in the general population; second, the rates 
of false negatives in the reagin tests due to the prozone 
effect (antigen excess) is greater; third, the reagin tests 
may remain positive in a greater number of cases and 
for a longer period of time (1). If conventional serology 
does not confirm syphilis in the case of clear clinical 
suspicion, PCR techniques using DNA polymerase I se-
quences have demonstrated sensitivity and specificity 
between 80-98% in the case of early syphilis (29). Pa-
tients coinfected with HIV and syphilis present a high-
er prevalence of treatment failure; nonetheless, as we 
mentioned above, treatment is the same as for non-HIV 
patients (1).
If we examine the other direction–that is, the influence 
of syphilis on HIV–it appears clear that the ulcerous le-
sions are related to an increased risk of HIV infection, 
since the chancre may be the infection’s access route. In 
addition, it has been reported that syphilis may increase 
immunological activation and cytokine secretion, thus 
favouring the replication of the virus (1). Recent stud-
ies have shown an increase in the viral load and a fall 
in the lymphocyte CD4 count in patients with HIV and 
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early syphilis (30), which obviously has a bearing on the 
control of the HIV infection.  
The comparison by countries (Table 1) shows that the 
rate of coinfection of syphilis and HIV varies according 
to the population analysed, together with other individ-
ual risk factors. However, given the ease of contact be-
tween different countries, these rates will tend to even 
out. To minimize the risk of spread of the infection, 
dentists have an important part to play in prevention 
and rapid diagnosis.  
Conclusion
Dentists must be aware of the oral and systemic manifes-
tations of the primary and secondary forms of syphilis, 
and should refer the cases they diagnose to the reference 
centres for sexually-transmitted diseases. The possible 
association of syphilis with HIV and with other STDs 
should not be forgotten. Finally, dentists must inform 
their patients of the need to take preventive measures, 
not only in the practice of genital-anal sex but also in 
oral sex, which is often overlooked.
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